Armata Pharmaceuticals
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Armata Pharmaceuticals's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 18% to $4,529,000. Profit margin reached -1525%. Total operating expenses were $11,649,000.
Profit Margin
| 2014 | 409K | 23.10M | 5650.12% |
|---|---|---|---|
| 2015 | 475K | -516K | -108.63% |
| 2016 | 260K | -18.83M | -7245.38% |
| 2017 | 115K | -12.83M | -11163.48% |
| 2018 | 0 | -12.11M | |
| 2019 | 0 | -19.02M | |
| 2020 | 823K | -22.81M | -2772.17% |
| 2021 | 4.47M | -23.21M | -518.98% |
| 2022 | 5.50M | -36.88M | -669.72% |
| 2023 | 4.52M | -69.04M | -1524.51% |
ARMP Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 4.52M | 5.50M | 4.47M | 823K | 0 | 0 | 115K | 260K | 475K | 409K |
Cost of revenue | 33.77M | 892K | 20.01M | 14.44M | 1.35M | 0 | 374K | 0 | 0 | 0 |
Gross profit | -29.24M | 4.61M | -15.54M | -13.62M | -1.35M | 0 | -259K | 260K | 475K | 409K |
Operating exp. | ||||||||||
Research and development | 33.77M | 35.01M | 20.01M | 14.44M | 9.82M | 4.89M | 2.88M | 5.67M | 3.99M | 5.80M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 289K | 1.86M |
Total operating expenses | 11.64M | 36.94M | 23.82M | 21.58M | 19.08M | 10.59M | 10.47M | 14.09M | 10.70M | 14.51M |
Operating income | -40.89M | -36.94M | -23.82M | -21.58M | -19.75M | -12.52M | -16.15M | -23.37M | -10.22M | -14.11M |
Other income (expenses), net | -28.15M | 29K | 667K | -594K | 273K | -1.84M | 2.01M | -5.56M | 9.63M | 37.21M |
Income before tax | -69.04M | -36.91M | -23.15M | -22.18M | -19.47M | -12.43M | -14.14M | -19.39M | -589K | 23.10M |
Income tax expense | 0 | -29K | 64K | 634K | -454K | -328K | -1.30M | -556K | -73K | -37.21M |
Net income | -69.04M | -36.88M | -23.21M | -22.81M | -19.02M | -12.11M | -12.83M | -18.83M | -516K | 23.10M |
Earnings per share | ||||||||||
Basic EPS | -1.91 | -1.08 | -0.96 | -1.39 | -2.43 | -8.9 | -28.14 | -268.06 | -13.35 | 589.4 |
Diluted EPS | -1.91 | -1.08 | -0.96 | -1.39 | -2.43 | -8.9 | -27.34 | -268.06 | -13.35 | -326.2 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |